30
Views
4
CrossRef citations to date
0
Altmetric
Article

Comparison of a peanut agglutinin test and an immunochemical faecal occult blood test in detecting colorectal neoplasia in symptomatic patients

, , &
Pages 140-145 | Received 01 Dec 2003, Accepted 14 Jan 2004, Published online: 08 Jul 2009

REFERENCES

  • Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365–71.
  • Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472–77.
  • Kronborg O, Fenger C, Sondergaard O, Pederson KM, Olsen J. Randomised study of screening for colorectal cancer by faecal occult blood test. Lancet 1996; 348: 1467–71.
  • Mapp TJ, Hardcastle JD, Moss SM, Robinson MHE. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening. Br J Surg 1999; 86: 1286— 91.
  • Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989; 63: 1826— 30.
  • Sidranski D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102–4.
  • Shamsuddin AM. New assays for detection of colorectal cancer. In: Shamsuddin AM, editor. Diagnostic assays for colon cancer. Boca Raton, FL: CRC Press; 1991. p. 103–14
  • Roseth AG, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, Roald B. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993; 28: 1073–6.
  • Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000; 119: 1219–27.
  • Rhodes JM, Black RR, Savage A. Glycoprotein abnormalities in colonic carcinomata, adenomata and hyperplastic polyps shown by lectin-peroxidase histochemistry. J Clin Pathol 1986; 39: 1331–4.
  • Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest 1995; 95: 571–6.
  • Shamsuddin AM, Elsayed AM. A test for detection of colorectal cancer. Hum Pathol 1988; 19: 7–9.
  • Sakamoto K, Muratani M, Ogawa T, Nagamachi Y. Evaluation of a new test for colorectal neoplasms: a prospective study of asymptomatic population. Cancer Biother 1993; 8: 49–54.
  • Kellokumpu IH, Andersson LC, Kellokumpu SJ. Detection of colorectal neoplasia with peanut-agglutinin (PNA)-reactive carbohydrate struc-tures in rectal mucus. Int J Cancer 1997; 74: 648–53.
  • Väänänen P, Tenhunen R. Rapid immunochemical detection of fecal occult blood by use of latex-agglutination test. Clin Chem 1988; 34: 1763–6.
  • Morson BC, Dawson IMP. Gastrointestinal patho-logy. 2nd ed. Oxford: Blackwell Scientific Pub-lications; 1979. p. 615–80.
  • Nixon JB, Riddell RH. Histopathology of ulcerative colitis. In: Allan RN, Keighley MRB, Alexander-Williams J, Hawkins C, editors. Inflam-matory bowel diseases. 2nd ed. Edinburgh: Churchill Livingstone; 1990. p. 247–62.
  • Thompson H. Histopathology of Crohn's disease. In: Allan RN, Keighley MRB, Alexander-Williams J, Hawkins C, editors. Inflammatory bowel diseases. 2nd ed. Edinburgh: Churchill Livingstone; 1990. p. 263–85.
  • Armitage P, Berry G. Statistical methods in medical research. 2nd ed. London: Blackwell Scientific Publications; 1987.
  • Robinson M, Marks C, Farrands P, Thomas W, Hardcastle J. Population screening for colorectal cancer: comparison between guaiac and immuno-logical faecal occult blood tests. Br J Surg 1994; 81: 448–51.
  • Thomas WM, Hardcastle JD, Jackson J, Pye G. Chemical and immunological testing for faecal occult blood: a comparison of two tests in symptomatic patients. Br J Cancer 1992; 65: 618— 20.
  • Robinson M, Kronborg O, Williams C, Bostock K, Rooney P, Hunt L, Hardcastle J. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. Br J Surg 1995; 82: 318–20.
  • Hardcastle JD, Pye G. Screening for colorectal cancer: a critical review. World J Surg 1989; 13: 38 — 44.
  • Jass JR. Hyperplastic polyps of the colorectum—innocent or guilty? Dis Col Rectum 2001; 44: 163–6.
  • Winaver S, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow C, Woolf S, Glick S, Ganiats T, Bond J, Rosen L, Zapka J, Olsen S, Giardiello F, Sisk J, Antwerp van R, Brown-Davis C, Marciniak D, Mayer R. Colorectal cancer screen-ing: clinical guidelines and rationale. Gastroenter-ology 1997; 112: 594–642.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.